Intro

This chapter delves into Bupropion's history as an antidepressant and smoking cessation aid while explaining its unique classification as an NDRI. The speakers highlight its effects on neurotransmitters and discuss the medication's potential advantages, especially for specific patient groups, despite its underutilization in clinical settings.